COVID-19 Vaccine Candidate Induces Immune Response in All Phase 1 Participants
The mRNA-1273 vaccine candidate from Moderna will progress to a phase 3 trial in adults later this summer.
The mRNA-1273 vaccine candidate from Moderna will progress to a phase 3 trial in adults later this summer.
Despite overall reductions, the elderly remain vulnerable to severe COVID-19 outcomes.
Spare use of carbapenem-sparing regimens reflects practice lagging behind guidance, among the challenges in implementing antimicrobial stewardship.
New data from a World Health Organization (WHO) repository illustrates the treatment challenges during the acute phase of the pandemic.
According to the latest Centers for Disease Control and Prevention (CDC) data, these strains have increased in incidence rates, and now account for nearly a…
The accuracy of ICD-10 varied depending on the patient’s age, how the influenza season was defined, the time interval between symptom onset and testing, and…
The Department of Agriculture has initiated proactive measures, collaborating with federal agencies, to ensure the safety of the nation’s meat supply.
According to the latest Centers for Disease Control and Prevention (CDC) data, these strains have increased in incidence rates, and now account for nearly a…
An analysis reveals rising hospitalization rates among pregnant women with hepatitis C virus (HCV) and their age as a critical factor influencing maternal and fetal…
The modified difference-in-differences analysis found notable increases in DAA use after state Medicaid programs relaxed certain coverage restrictions.
In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).